La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Canada7508
Yoshiaki Furukawa24
Canada Sauf Yoshiaki Furukawa" 7485
Yoshiaki Furukawa Sauf Canada" 1
Canada Et Yoshiaki Furukawa 23
Canada Ou Yoshiaki Furukawa 7509
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 23.
Ident.Authors (with country if any)Title
000470 Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
000595 Yoshiaki Furukawa [Japon] ; Stephen J. Kish [Canada]Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia.
000658 Junchao Tong [Canada] ; Lee-Cyn Ang [Canada] ; Belinda Williams [Canada] ; Yoshiaki Furukawa [Japon] ; Paul Fitzmaurice [Nouvelle-Zélande] ; Mark Guttman [Canada] ; Isabelle Boileau [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada]Low Levels of Astroglial Markers in Parkinson's Disease: Relationship to α-Synuclein Accumulation
001685 Junchao Tong [Canada] ; Isabelle Boileau [Canada] ; Yoshiaki Furukawa [Japon] ; Li-Jan Chang [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Stephen J. Kish [Canada]Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies
001A40 Junchao Tong [Canada] ; Yoshiaki Furukawa [Canada, Japon] ; Allan Sherwin [Canada] ; Oleh Hornykiewicz [Autriche] ; Stephen J. Kish [Canada]HETEROGENEOUS INTRASTRIATAL PATTERN OF PROTEINS REGULATING AXON GROWTH IN NORMAL ADULT HUMAN BRAIN
001B39 Junchao Tong [Canada] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Lee C. Ang [Canada] ; Lysia S. Forno [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Manfred D. Muenter [États-Unis] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada, Japon]Brain -synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation
001D28 Stephen J. Kish [Canada] ; Jason Lerch [Canada] ; Yoshiaki Furukawa [Canada, Japon] ; Junchao Ton [Canada] ; Tina Mccluskey [Canada] ; Diana Wilkins [États-Unis] ; Sylvain Houle [Canada] ; Jeffrey Meyer [Canada] ; Emanuela Mundo [Italie] ; Alan A. Wilson [Canada] ; Pablo M. Rusjan [Canada] ; Jean A. Saint-Cyr [Canada] ; Mark Guttman [Canada] ; D. Louis Collins [Canada] ; Colin Shapiro [Canada] ; Jerry J. Warsh [Canada] ; Isabelle Boileau [Canada]Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study
001D37 JUNCHAO TONG [Canada] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Lee C. Ang [Canada] ; Lysia S. Forno [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Ali H. Rajput [Canada] ; Manfred D. Muenter [États-Unis] ; Stephen J. Kish [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada, Japon]Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation
001F26 Isabelle Boileau [Canada, Niger] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada]Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease
002238 Stephen J. Kish [Canada, Niger] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Canada] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada]Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
002B52 Yoshiaki Furukawa [Canada]Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.
002B99 Yoshiaki Furukawa [Canada] ; James J. Filiano ; Stephen J. KishAmantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.
002C84 Junchao Tong [Canada] ; Paul S. Fitzmaurice ; Lee Cyn Ang [Royaume-Uni] ; Yoshiaki Furukawa [Canada] ; Mark Guttman ; Stephen J. KishBrain dopamine‐stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
002D90 Mark Guttman [Canada] ; Stephen J. Kish ; Yoshiaki FurukawaCurrent concepts in the diagnosis and management of Parkinson's disease.
002E13 Raúl De La Fuente-Fernández [Canada] ; Sarah Furtado [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]VMAT2 binding is elevated in dopa‐responsive dystonia: Visualizing empty vesicles by PET
002E43 Paul S. Fitzmaurice [Canada] ; Lee Ang [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada]Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
002E71 Ronald B. Postuma [Canada, États-Unis] ; Yoshiaki Furukawa [Canada, États-Unis] ; Ekaterina Rogaeva [Canada, États-Unis] ; Peter H. St. George-Hyslop [Canada, États-Unis] ; Matt J. Farrer [Canada, États-Unis] ; Anthony E. Lang [Canada, États-Unis]Dopa‐responsive dystonia presenting with prominent isolated bilateral resting leg tremor: Evidence for a role of parkin?
002F12 Sophie Vigouroux [France] ; Yoshiaki Furukawa [Canada] ; Luc Farout [France] ; Stephen J. Kish [Canada] ; Marièle Briand [France] ; Yves Briand [France]Peptidase activities of the 20/26S proteasome and a novel protease in human brain
002F33 Yoshiaki Furukawa [Canada]Genetics and biochemistry of dopa-responsive dystonia: Significance of striatal tyrosine hydroxylase protein loss
003035 Yoshiaki Furukawa [Canada] ; Gregory Kapatos [États-Unis] ; John W. Haycock [États-Unis] ; Julian Worsley [Canada] ; Henry Wong [Canada] ; Stephen J. Kish [Canada] ; Torbjoern G. Nygaard [États-Unis]Brain biopterin and tyrosine hydroxylase in asymptomatic dopa‐responsive dystonia
003099 Yoshiaki Furukawa [Canada] ; Sophie Vigouroux [France] ; Henry Wong [Canada] ; Mark Guttman [Canada] ; Ali H. Rajput [Canada] ; LEE ANG [Canada] ; Marièle Briand [France] ; Stephen J. Kish [Canada] ; Yves Briand [France]Brain proteasomal function in sporadic Parkinson's disease and related disorders
003511 Yoshiaki Furukawa [Canada] ; Mark Guttman [Canada] ; Steven P. Sparagana [États-Unis] ; Joel M. Trugman [États-Unis] ; Keith Hyland [États-Unis] ; Philip Wyatt [Canada] ; Anthony E. Lang [Canada] ; Guy A. Rouleau [Canada] ; Mitsunobu Shimadzu [Japon] ; Stephen J. Kish [Canada]Dopa‐responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene
003986 Yoshiaki Furukawa [Canada] ; Stephen J. Kish [Canada] ; E. Martina Bebin [États-Unis] ; Richard D. Jacobson [États-Unis] ; Julie S. Fryburg [États-Unis] ; Willam G. Wilson [États-Unis] ; Mitsunobu Shimadzu [Japon] ; Keith Hyland [États-Unis] ; Keith Trugman [États-Unis]Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022